definiens: shall mean ANDA Nos . and ( relating to acontent in which such ANDAs exists as of the Effective Date, ( subject to amendmentspennitted by FDA rules and regulations ), and the subsequent ANDA owned or controlledby Spectrum covering the ' G .S shall mean the prescriptiongeneric Sumatriptan Succinate injection product ( i ) in the 2 m mI 5mL via fomldeveloped and manufactured by Spectrum for human use in the United States and ( ii ) anynot given notice of its cOlmnitment to so supply ( on an exclusive or non - exclusive basis)Specttum with a Generic Equivalent of the Imitrex ® 6 m " Stat - D se retill cartrid,,!'presentation, Spectrum Generic Sumatriptan Injection Products shall also include theprescription generic Sumatriptan Succinate injection product in the i51 d ' presentation for human use in the United States that is the generic to [COMPANY] 's Imitrex ® (Sumatriptan Succinate ) injection product in the Gm 1Stat - Dose refill cal1ridgpresentation approved under [COMPANY] 's NDA No . 02 008